Alzheimer's disease & dementia

Antioxidant may disrupt Alzheimer's disease process

Alzheimer's disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing ...

Medical research

Cholesterol sets off chaotic blood vessel growth

A study at the University of California, San Diego School of Medicine identified a protein that is responsible for regulating blood vessel growth by mediating the efficient removal of cholesterol from the cells. Unregulated ...

Diseases, Conditions, Syndromes

Convalescent plasma is latest COVID-19 therapy

Richard Beckerson will never know whether it was convalescent plasma that made the lifesaving difference—or whether it was the antiviral drug remdesivir or a combination of both.

Immunology

New target identified to combat deadly allergic reactions

Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions. The study, "Kinesin-1 controls mast cell degranulation and anaphylaxis ...

Oncology & Cancer

Heart medication converts cancer cells into vaccine

(HealthDay) -- A class of heart medications, cardiac glycosides, can induce immunogenic cell death (ICD), whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according to a study published ...

Medical research

Awaiting orders to retaliate

(Medical Xpress) -- When immune system B cells are alerted to the presence of a threat within the body, they form structures called germinal centers, which serve as ad hoc headquarters for marshaling a targeted immune response. ...

Diseases, Conditions, Syndromes

Researchers identify new target for creating flavivirus vaccines

The results of a recent study moved University of Arizona Health Sciences researchers one step closer to developing effective vaccinations against flaviviruses, which infect more than 400 million people a year with diseases ...

Neuroscience

Study measures brain volume differences in people with HIV

Nearly 38 million people around the world are living with HIV, which, with access to treatment, has become a lifelong chronic condition. Understanding how infection changes the brain, especially in the context of aging, is ...

page 24 from 40